Sjogren's Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Recent evidences have revealed that anti-SSA/SSB antibodies, the major autoantibodies in Sjögren's syndrome (SS), are produced in salivary glands.
|
31611218 |
2020 |
Sjogren's Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
All participants in the SICCA registry who were found to have any objective measures of salivary hypofunction, dry eye, focal lymphocytic sialadenitis in minor salivary gland biopsy, or anti-SSA/SSB antibodies were recalled over a window of 2 to 3 years after their baseline examinations to repeat all clinical examinations and specimen collections to determine whether there was any change in phenotypic features and in SS status.
|
28437595 |
2018 |
Sjogren's Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
E. coli with autodisplayed La/SSB protein was used for an immunoassay of anti-La/SSB antibodies for the diagnosis of Sjögren's syndrome.
|
28284305 |
2017 |
Sjogren's Syndrome
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Defective DNA methylation in salivary gland epithelial acini from patients with Sjögren's syndrome is associated with SSB gene expression, anti-SSB/LA detection, and lymphocyte infiltration.
|
26725749 |
2016 |
Sjogren's Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
The elevated tissue expression of Ro/SSA and La/SSB autoantigens appears to be crucial for the generation and perpetuation of autoimmune humoral responses against these autoantigens in Sjögren's syndrome (SS).
|
26201309 |
2015 |
Sjogren's Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Targeted deletion of the gene encoding the La autoantigen (Sjögren's syndrome antigen B) in B cells or the frontal brain causes extensive tissue loss.
|
24190965 |
2014 |
Sjogren's Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
A number of systemic features have also been described and the presence of autoantibodies against the ubiquitously expressed ribonucleoprotein particles Ro (Sjögren's-syndrome-related antigen A - SSA) and La (SSB) further underline the systemic nature of Sjögren's syndrome.
|
21777618 |
2011 |
Sjogren's Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Conventional manifestations of fetal Sjogren's antibodies (SSA/SSB) associated cardiac disease include atrioventricular block (AVB), transient sinus bradycardia, endocardial fibroelastosis (EFE) and dilated cardiomyopathy.
|
19330707 |
2009 |
Sjogren's Syndrome
|
0.100 |
AlteredExpression
|
disease |
LHGDN |
Differential expression of Ro/SSA 60 kDa and La/SSB, but not Ro/SSA 52 kDa, mRNA and protein in minor salivary glands from patients with primary Sjögren's syndrome.
|
17552056 |
2007 |
Sjogren's Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Immunoblot analysis on two-dimensional gels using purified anti-La/SSB antibodies revealed that pSS salivary glands contain high levels of post-translationally modified La/SSB autoantigen, while the native form of the protein is recognized faintly, in contrast to normal controls.
|
17177966 |
2007 |
Sjogren's Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Thyroiditis, autoantibodies to Ro/SS-A, La/SS-B and ds-DNA was more frequent in the SS-SLE group than in patients with SLE.
|
17145372 |
2006 |
Sjogren's Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Fragmentation of autoantigens such as SS-B/La or alfa-fodrin during the process of apoptosis causes the redistribution of these autoantigens, leading to the production of autoantibodies in SS.
|
17162248 |
2006 |
Sjogren's Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
One hundred forty-nine white patients fulfilling the American-European Consensus Group criteria for SS were divided into 3 subgroups, according to their anti-Ro/SSA and anti-La/SSB status, as follows: group 1 (n = 53), no antibody; group 2 (n = 46), anti-SSA only; group 3 (n = 50), both anti-SSA and anti-SSB.
|
12905478 |
2003 |
Sjogren's Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Unmasking the anti-La/SSB response in sera from patients with Sjogren's syndrome by specific blocking of anti-idiotypic antibodies to La/SSB antigenic determinants.
|
12428060 |
2002 |
Sjogren's Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Interestingly, the incidence of antibodies to SS-56 was associated with visceral complications in SLE, and roughly half of the 17 SS or SLE patients with no detectable antibodies to SSA and SSB antigens presented measurable antibodies against recombinant SS-56.
|
11560955 |
2001 |
Sjogren's Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
There was a strong correlation between clinical signs and corresponding autoantibodies such as anti-SSA and -SSB antibodies in Sjögren's syndrome (10 cases), antithyroid peroxidase antibodies in thyroiditis and Graves' disease (10 cases), and parietal cell antibodies in gastric ulcers with maltoma (12 cases).
|
10205590 |
1999 |
Sjogren's Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Phage clones selected for the presence of insert both by gene and antigenic analyses were used in the ELISA to detect anti-La/SS-B antibodies from patients with Sjogren's syndrome and SLE.
|
9237100 |
1997 |
Sjogren's Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Several different groups of SS sera previously tested for Ro and La(SSB) autoantibodies in clinical diagnostic labs were tested by ELISA with a recombinant human 52 kDa Ro fusion protein.
|
9150073 |
1997 |
Sjogren's Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
One gene, two transcripts: isolation of an alternative transcript encoding for the autoantigen La/SS-B from a cDNA library of a patient with primary Sjögrens' syndrome.
|
7964483 |
1994 |
Sjogren's Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
The three mothers were found to suffer from Sjögren's syndrome; they all tested positive for anti-SSA and SSB antibodies and had lymphocyte infiltration into the small salivary gland.
|
1607484 |
1992 |
Sjogren's Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
SS-B/La is a major antigenic target for autoantibodies in patients with Sjögren's syndrome.
|
2476998 |
1989 |
Sjogren's Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Because the SS-A/Ro and SS-B/La autoantibody responses in SS and systemic lupus erythematosus (SLE) show even stronger correlations with HLA alleles, HLA-DR and DQ alleles were examined using restriction fragment length polymorphisms (RFLP) in white and black patients with SS and/or SS having anti-Ro and anti-La antibodies.
|
2571337 |
1989 |